Amarin Corp Plcuk (AMRN) Asset Utilization Ratio (2013 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Asset Utilization Ratio of 0.33 for Q1 2026, up 3.12% YoY from 0.32 in Q1 2025, and up 2.54% sequentially from 0.32 in Q4 2025.
Amarin Corp Plcuk (AMRN) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Asset Utilization Ratio across 14 years of filings, most recently posting 0.33 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 3.12% year-over-year to 0.33; the TTM figure through Mar 2026 stood at 0.33 (up 3.12% YoY), while the FY2025 annual figure was 0.32, up 4.54% from the prior year.
- Asset Utilization Ratio advanced to 0.33 in Q1 2026, from 0.32 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for AMRN reached as high as 0.52 in Q1 2022 and fell as low as 0.31 in Q3 2024.
- The 5-year median for Asset Utilization Ratio is 0.34 (2024), against an average of 0.38.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio slipped 25.78% — and 2025, when it grew 9.67%.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.41 in 2022, then slipped by 10.71% to 0.37 in 2023, then declined by 13.33% to 0.32 in 2024, then grew by 0.85% to 0.32 in 2025, then gained by 2.54% to 0.33 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.33, 0.32, and 0.34 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.63 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.48 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.46 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 0.50 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.12 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.33 |
| Dec 31, 2025 | 0.32 |
| Sep 30, 2025 | 0.34 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.32 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.34 |
| Dec 31, 2023 | 0.37 |
| Sep 30, 2023 | 0.38 |
| Jun 30, 2023 | 0.40 |
| Mar 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.49 |
| Mar 31, 2022 | 0.52 |
| Dec 31, 2021 | 0.55 |
| Sep 30, 2021 | 0.58 |
| Jun 30, 2021 | 0.61 |